Patents Assigned to PHI BioMed Co., Ltd.
  • Patent number: 10613356
    Abstract: One aspect of the present disclosure relates to a remotely controllable lens device. The lens device can include a lens material and a circuit physically coupled to the lens material. The circuit can be configured to be powered based on an energy signal from a power source to perform a function (e.g., release of drug, generation of electromagnetic radiation, detection of electromagnetic radiation, and/or control of an optical refractive property). For example, the power source can be an external power source and/or an auto-powered source. The external power source can be, for example, a power source that utilizes synchronized magnetic flux phase coupling (e.g., WiTricity). The auto-powered source can be provided on-site (e.g., on-chip) using a harvesting system (e.g., solar-cell, photo-cell, piezoelectric, etc.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: April 7, 2020
    Assignees: The General Hospital Corporation, Phi Biomed Co., Ltd.
    Inventors: Seok-Hyun Yun, Ehsan Kamrani, Sei Kwang Hahn, Hyemin Kim, Dohee Keum, Keon Jae Lee, Choun-Ki Joo
  • Patent number: 10399291
    Abstract: The present invention provides a smart contact lens including a sensor capable of non-invasively sensing an eye disease in real time and a drug reservoir, and smart glasses for controlling the smart contact lens.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: September 3, 2019
    Assignee: PHI BIOMED CO., LTD.
    Inventors: Sei Kwang Hahn, Young Chul Sung, Beom Ho Mun, Keon Jae Lee, Dohee Keum, Su Jin Kim
  • Patent number: 10092658
    Abstract: A transdermal delivery system of drug and a method of preparing the same are provided. More specifically, the invention can be a transdermal delivery system applied for various protein drugs such as vaccines and chemical drugs, because the drug delivery system has a biocompatibility, biodegradation property, transdermal delivery property, the safety of human body, maximum activity of protein drugs, good bio-conjugation efficiency and a long-term efficacy, a method of preparing the same and its use.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: October 9, 2018
    Assignee: PHI BIOMED CO., LTD.
    Inventors: Sei Kwang Hahn, Eung-Sam Kim, Jeonga Yang, Hyemin Kim, Kwan Yong Choi, Ji Hye Shin, Jung-Hee Kwon
  • Publication number: 20150056254
    Abstract: A transdermal delivery system of drug and a method of preparing the same are provided. More specifically, the invention can be a transdermal delivery system applied for various protein drugs such as vaccines and chemical drugs, because the drug delivery system has a biocompatibility, biodegradation property, transdermal delivery property, the safety of human body, maximum activity of protein drugs, good bio-conjugation efficiency and a long-term efficacy, a method of preparing the same and its use.
    Type: Application
    Filed: February 7, 2013
    Publication date: February 26, 2015
    Applicant: PHI BioMed Co., Ltd.
    Inventors: Sei Kwang Hahn, Eung-Sam Kim, Jeonga Yang, Hyemin Kim, Kwan Yong Choi, Ji Hye Shin, Jung-Hee Kwon